Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults

The emergence of Omicron variants coincided with declining vaccine-induced protection against SARS-CoV-2. Two bivalent mRNA vaccines, mRNA-1273.222 (Moderna) and BNT162b2 Bivalent (Pfizer-BioNTech), were developed to provide greater protection against the predominate circulating variants by includin...

Cijeli opis

Bibliografski detalji

Glavni autori:	Hagit Kopel, Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Isabelle Winer, Thierry Ducruet, Ni Zeng, Mac Bonafede, Daina B. Esposito, David Martin, Andrew Rosen, Nicolas Van de Velde, Sten H. Vermund, Stefan Gravenstein, James A. Mansi
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2023-11-01
Serija:	Vaccines
Teme:	mRNA-1273.222 BNT162b2 Bivalent vaccine bivalent vaccine COVID-19 vaccine hospitalization symptomatic disease
Online pristup:	https://www.mdpi.com/2076-393X/11/11/1711
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!